GI (pt 3/5) PPIs, GI Prokinetic Drugs Flashcards
PPIs inhibit ___-___% of acid secretion (!BlueBox!)
PPIs inhibit 90% -98% of acid secretion.
Released in the late 1980s – have assumed the major role for the treatment of acid-peptic disorders-GI Bleed or past bleed- increase dose as bolus or give 2X day then start Iv continuous.
-Among the most widely prescribed drugs in the world
Proton Pump Inhibitors (PPIs)
What is the MOA of Proton Pump Inhibitors (PPIs)?
Produce selective & irreversible inhibition of the proton (acid) pump enzyme system (H+/K+-ATPase) of the parietal cells of the stomach.
-Cause prolonged inhibition of gastric acid secretion regardless of the stimulus
How do PPIs compare to H2 Blockers?
PPIs have significantly greater inhibition than H2 Blockers
Explain the dosing/administration of PPIs.
-Single PO dose the night before surgery improves the pH of the gastric fluid
-No difference if taken less than 3hr before surgery (so take night before or >3 hrs before surgery)
-Duration of action ~ 24hr or more
-18 hrs required for synthesis of H+/K+-ATPase pump molecules
-Given as inactive drug-changes when coating dissolves= Prodrug
Explain how PPIs are converted from the inactive prodrug to the activated form?
1) Administered as an inactive prodrug
2) In the alkaline intestinal lumen, the enteric coating dissolves and the prodrug is absorbed
3) PPIs are lipophilic weak bases (pKa 4-5), so they readily cross the lipid membranes into acidified compartments (Such as the parietal cell)
4) Prodrug rapidly becomes protonated within the canaliculus
Why are PPIs “ideal drugs” regarding pharmacokinetics? (Blue Box!!)
Regarding pharmacokinetics, PPIs are ideal drugs: they have a short serum half-life, they are concentrated and activated near the site of action and have a long duration of action.
Bioavailability of PPIs is decreased ___% by food.
Bioavailability is decreased 50% by food.
-Administer 1 hr before a meal (typically before breakfast)
-Allows for peak serum concentration to coincide with high proton-pump secretion activity
-Only 10% of pumps are working during the fasting state
What is important to know regarding PPIs and Liver impairment?
Dose reduction needed in severe liver impairment.
To maximize inhibition during the first 24-28hrs, IV doses of Esomeprazole and Pantoprazole must be given as ___________ or __________.
To maximize inhibition during the first 24-28hrs, IV doses of Esomeprazole and Pantoprazole must be given as continuous infusions or repeated boluses.
Are all active proton pumps inhibited with the first dose of PPI?
No; Not all active pumps are inhibited with the first dose.
-Takes 3-4 days before the full acid-inhibiting potential in reached
-Similar 3-4 days for recovery after D/C of the drug
Acid inhibition from PPIs last how long?
-Acid Inhibition lasts for up to 24 hrs
-Half-life is 1.5 hrs
What are the drug interactions that occur with Proton Pump Inhibitors (PPIs)?
-↓Gastric acidity may alter absorption of anti-fungals, anti-virals.
-All PPIs are metabolized by hepatic CYP450, so they increase concentration of drugs metabolized by these pathways.
-Specific considerations with Omeprazole, Esomeprazole, and Lansoprazole
What are the specific drug interactions that occur with Omeprazole (Prilosec)?
-Increases levels of Valium, Dilantin, and Coumadin
-Decreases effectiveness of Plavix (blocks an enzyme, CYP2C19, that turns Plavix into its active form).
What are the specific drug interactions that occur with Esomeprazole (Nexium)?
-Diazepam
-Decreases effectiveness of Plavix (blocks an enzyme, CYP2C19, that turns Plavix into its active form).
What are the specific drug interactions that occur with Lansoprazole (Prevacid)?
-Theophylline
What are the specific drug interactions that occur with Rabeprazole and Pantoprazole (Protonix)?
No significant drug interactions.
What are the adverse effects associated with PPIs?
In general, extremely safe drugs.
-1-5% report diarrhea, HA & ABD Pain
-↓ B12 levels & calcium absorption with prolonged use (may need B12 injections)
-↑ risk of community-acquired respiratory infections & nosocomial pneumonia
-↑ risk for hospital & community-acquired Clostridium difficile infections in patients on PPIs
-Risk of transient rebound acid hypersecretion after drug discontinuation
-Change absorption of minerals and medications (risk of Fx)